🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00128830
This multicenter, international, non randomized (single arm), open, phase I...
Status
Completed
Location
Hôpital Avicenne
Start Date
2015-01
Trial ID
NCT02212379
Treatments Being Tested
The purpose of this study is to learn more about the safety and tolerabilit...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01422330
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
Spectrum Medical Group
Start Date
2015-11-18
Trial ID
NCT02605954
Treatments Being Tested
The purpose of this study is to investigate the pharmacokinetic interaction...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01876966
Treatments Being Tested
The purpose of this study is to provide etravirine (ETR) through this trial...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-09
Trial ID
NCT00980538
Treatments Being Tested
The purpose of this study is to see the effect of etravirine or TMC278 on h...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01336829
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of elvitegra...
Status
Completed
Location
Midway Immunology & Research Center, LLC
Start Date
2015-12-17
Trial ID
NCT02616029
Treatments Being Tested
The purpose of this study is to determine the pharmacokinetics (how the bod...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00896051
The primary objective of this study is to evaluate the safety of elvitegrav...
Status
Completed
Location
CHU Saint-Pierre University Hospital
Start Date
2015-12-22
Trial ID
NCT02616783